Table 2.
Laboratory values, expressed as median ± interquartile range, at admission and 5 days of patients with COVID-19 overall, and in those who survived or died.
| Overall | Dead | Discharged | p | |
|---|---|---|---|---|
| Admission | ||||
| Radiography at admission | ||||
| Normal (0 points) | 27 (8.6%) | 1 (1.3%) | 26 (10.9%) | <0.001 |
| Mild (1–2 points) | 72 (23%) | 11 (14.7%) | 61 (25.6%) | |
| Moderate (3–6 points) | 151 (48.2%) | 36 (48%) | 115 (48.3%) | |
| Severe (>6 points) | 63 (20.1%) | 27 (36%) | 36 (15.1%) | |
| Hemoglobin, g/dL | 13 ± 2.6 | 13 ± 3 | 13 ± 2.5 | 0.899 |
| Lymphocytes, 103/μL | 0.9 ± 0.7 | 0.6 ± 0.75 | 1 ± 0.6 | <0.001 |
| Creatinine, mg/dL | 0.8 ± 0.4 | 1.1± 0.5 | 0.9 ± 0.4 | <0.001 |
| D-dimer, ng/mL | 1.1 ± 1.3 | 2.1 ± 2.5 | 0.9 ± 1 | <0.001 |
| Ferritin, ng/mL | 584 ± 686 | 576.5 ± 881 | 584 ± 661 | 0.733 |
| AST, U/L | 29 ± 24.2 | 39 ± 33 | 27 ± 23 | 0.003 |
| ALT, U/L | 26 ± 29 | 27 ± 27 | 25 ± 29 | 0.756 |
| C-reactive protein, mg/L | 6.5 ± 12.2 | 16 ± 21.4 | 6 ± 9 | <0.001 |
| 5 days | ||||
| Hemoglobin, g/dL | 12.6 ± 2.8 | 12.3 ± 3 | 12.7 ± 2.9 | 0.904 |
| Lymphocytes, 103/μL | 0.9 ± 07 | 0.55 ± 0.6 | 1 ± 2.4 | 0.007 |
| Creatinine, mg/dL | 0.8 ± 0.3 | 1 ± 0.6 | 0.8 ± 0.4 | 0.022 |
| D-dimer, ng/mL | 1 ± 2.1 | 2.5 ± 5.3 | 0.9 ± 2 | 0.025 |
| Ferritin, ng/mL | 650 ± 1187 | 563 ± 1300 | 669 ± 1206 | 0.999 |
| AST, U/L | 28 ± 24 | 38 ± 62.5 | 27 ± 21 | 0.038 |
| ALT, U/L | 28.5 ± 40 | 41 ± 40.8 | 28 ± 40 | 0.300 |
| C-reactive protein, mg/L | 3.3 ± 6 | 11.1 ± 19.3 | 3.1 ± 5 | 0.034 |